Paper Details

  1. Home
  2. Paper Details

Side-effects of post-treatment biopsies in prostate cancer patients treated with endocrine therapy alone or combined with radical radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial.

Author: AhlgrenGöran, AngelsenAnders, SolbergArne, TasdemirIlker, WidmarkAnders

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Patient-reported post-treatment prostate biopsy side-effects were mild and self-limiting. Pain at biopsy was reported in 63% (mild, 57%; moderate, 5.6%; severe, one patient) and pain at follow-up in 31% (mild, 27%; moderate, four patients). Haematuria (mean duration 2.2 days) was reported in 41%, and reduced urinary flow in 20%.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: Post-treatment prostate biopsy side-effects were evaluated in patients with locally advanced prostate cancer on endocrine therapy alone or combined with radiotherapy in the Scandinavian Prostate Cancer Group-7 randomized trial. MATERIAL AND METHODS: One-hundred and twenty patients underw...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3109/00365599.2011.560577

データ提供：米国国立医学図書館（NLM）

Post-Treatment Biopsies: Evaluating Side Effects in Prostate Cancer Patients

Prostate cancer treatment often involves post-treatment biopsies to monitor disease progression. This study evaluated the side effects of post-treatment biopsies in patients with locally advanced prostate cancer who had received either endocrine therapy alone or combined with radiotherapy. The researchers surveyed 109 patients, finding that previous therapy had no significant influence on pain, urinary flow, hematuria, or hematospermia. The most common side effect was pain during the biopsy, reported by 63% of patients. Other reported side effects included hematuria, reduced urinary flow, and rectal bleeding, with the latter being more frequent in the combined therapy group.

Post-Treatment Biopsies: A Balancing Act Between Monitoring and Side Effects

This study highlights the importance of balancing the need for post-treatment biopsies with the potential for side effects. While biopsies are essential for monitoring disease progression, it's crucial to consider the potential discomfort and risks associated with the procedure. The findings underscore the importance of open communication between patients and their healthcare providers to make informed decisions about biopsy frequency and management.

Navigating Prostate Cancer Treatment: Understanding Biopsy Considerations

This research provides valuable insights for patients undergoing prostate cancer treatment, particularly regarding post-treatment biopsies. The study highlights the potential side effects of biopsies and emphasizes the importance of open communication with healthcare professionals. This knowledge can help patients make informed decisions about biopsy frequency and management, ultimately contributing to their overall well-being.

Dr. Camel's Conclusion

This study sheds light on the side effects associated with post-treatment biopsies in prostate cancer patients. The findings underscore the importance of considering individual patient needs and preferences when making decisions about biopsy frequency and management.

Date :
  1. Date Completed 2012-01-19
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

21452932

DOI: Digital Object Identifier

10.3109/00365599.2011.560577

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.